Biopharmaceutical Contract Manufacturing Market Is Estimated to Be Valued at US$ 5,625.0 Mn by the End of 2017
Monoclonal Antibodies to Remain Largest and Most Lucrative Segment by Product Type in the Global Biopharmaceutical Contract Manufacturing Market
View full press release